Gilead Sciences (GILD) Current Taxes (2009 - 2015)
Gilead Sciences' (GILD) quarterly Current Taxes came in at $356.0 million in Q2 2015, up 265.87% YoY from $97.3 million in Q2 2014, and up 263.27% on a QoQ basis from $98.0 million in Q1 2015.
Gilead Sciences (GILD) Current Taxes (2009 - 2015) Analysis & Trends
Gilead Sciences (GILD) has 7 years of Current Taxes data on file, last reported at $356.0 million in Q2 2015.
- Quarterly Current Taxes rose 265.87% year-over-year to $356.0 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $356.0 million (up 265.87% YoY) and the FY2014 annual result came in at $105.0 million, up 854.55% from the prior year.
- Current Taxes climbed to $356.0 million in Q2 2015, from $98.0 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $356.0 million in Q2 2015 to a low of $2.5 million in Q1 2011.
- A 5-year average of $59.5 million and a median of $26.5 million in 2011 frame the typical range for Current Taxes.
- The widest YoY moves for Current Taxes: up 2079.54% in 2011, down 93.62% in 2011.
- Tracing GILD's Current Taxes over 5 years: stood at $40.6 million in 2011, then tumbled by 66.97% to $13.4 million in 2012, then slipped by 17.93% to $11.0 million in 2013, then soared by 854.55% to $105.0 million in 2014, then jumped by 239.05% to $356.0 million in 2015.
- The last three Current Taxes figures came in at $356.0 million (Q2 2015), $98.0 million (Q1 2015), and $105.0 million (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 356.00 Mn |
| Mar 31, 2015 | 98.00 Mn |
| Dec 31, 2014 | 105.00 Mn |
| Sep 30, 2014 | 43.78 Mn |
| Jun 30, 2014 | 97.30 Mn |
| Mar 31, 2014 | 152.95 Mn |
| Dec 31, 2013 | 11.00 Mn |
| Sep 30, 2013 | 10.65 Mn |
| Jun 30, 2013 | 37.97 Mn |
| Mar 31, 2013 | 19.24 Mn |
| Dec 31, 2012 | 13.40 Mn |
| Sep 30, 2012 | 17.09 Mn |
| Jun 30, 2012 | 11.85 Mn |
| Mar 31, 2012 | 14.49 Mn |
| Dec 31, 2011 | 40.58 Mn |
| Sep 30, 2011 | 33.67 Mn |
| Jun 30, 2011 | 5.44 Mn |
| Mar 31, 2011 | 2.46 Mn |
| Dec 31, 2010 | 1.86 Mn |
| Sep 30, 2010 | 38.71 Mn |